About this Research Topic
Such imbalances are frequently observed in animal models harboring genetic modifications of ASD‐associated genes, and their pharmacological correction has the potential to normalize key autistic-like phenotypes in these animals. Although the hypothesis that E/I imbalance contributes to development and maintenance of ASDs has widely been accepted and some candidate mechanisms underlying E/I imbalances in animal models of ASDs have been identified, additional studies are needed to better understand the causal relationship between E/I imbalance and autistic-like phenotypes. Neuronal E/I balance is established and tightly regulated by several factors at synaptic or circuit levels. Specific factors that contribute to synaptic E/I balance include excitatory/inhibitory synapse development, synaptic transmission and plasticity, downstream signaling pathways, homeostatic synaptic plasticity, and intrinsic neuronal excitability. At the circuit level, E/I balance involves local circuits such as the interplay between GABAergic interneurons and target pyramidal neurons, which modulate long-range connections. Although several studies point to a local hyperconnectivity and long-range hypoconnectivity and disconnection between neural circuits in ASD, the pathogenic mechanisms underlying E/I imbalance in ASDs might be more complex than expected. Indeed, recent studies have begun to show that the same gene mutation leads to distinct synaptic E/I imbalances in different synapses, cell types, and brain regions at different time points. These findings highlight the importance of pursuing detailed and integrative analyses of E/I imbalances in studies of animal models of ASD. Understanding the different cellular environments and finely regulated time-windows influencing E/I imbalance in ASDs brains is not only required to improve basic understanding of the causal link between E/I imbalance and the initiation, development and maintenance of autistic-like phenotypes, but has important implications for developing better pharmacological treatments, as it may lead to individuating specific therapeutic windows to address aberrant neuronal development in ASDs. Therefore, in this Research Topic we welcome innovative studies, as well as reviews on this fascinating aspect in Neurodevelopmental and Autism Spectrum Disorders.
Keywords: E/I imbalance, Neurodevelopmental Disorders, Autism Spectrum Disorders, animal models, pharmacological treatments
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.